Published in Nat Commun on January 01, 2014
Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell. Mol Endocrinol (2014) 1.05
A unique PDZ domain and arrestin-like fold interaction reveals mechanistic details of endocytic recycling by SNX27-retromer. Proc Natl Acad Sci U S A (2014) 1.00
Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation. Part Fibre Toxicol (2014) 0.93
Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism. Arch Toxicol (2015) 0.88
Insights into β2-adrenergic receptor binding from structures of the N-terminal lobe of ARRDC3. Protein Sci (2014) 0.80
New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats. Sci Rep (2016) 0.76
Thioredoxin-Interacting Protein Mediates Apoptosis in Early Brain Injury after Subarachnoid Haemorrhage. Int J Mol Sci (2017) 0.75
Identification of Redox and Glucose-Dependent Txnip Protein Interactions. Oxid Med Cell Longev (2016) 0.75
Thioredoxin-interacting protein regulates haematopoietic stem cell ageing and rejuvenation by inhibiting p38 kinase activity. Nat Commun (2016) 0.75
Regulatory Role of Redox Balance in Determination of Neural Precursor Cell Fate. Stem Cells Int (2017) 0.75
The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling. Pharmacol Rev (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J (1998) 9.36
Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol (2009) 9.24
Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Expr Purif (1999) 5.90
Maximum-likelihood density modification using pattern recognition of structural motifs. Acta Crystallogr D Biol Crystallogr (2001) 4.36
Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem (1999) 3.67
The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell (1999) 3.67
Thioredoxin and related molecules--from biology to health and disease. Antioxid Redox Signal (2007) 3.50
Bayesian correlated MAD phasing. Acta Crystallogr D Biol Crystallogr (1997) 3.31
TXNIP regulates peripheral glucose metabolism in humans. PLoS Med (2007) 3.27
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol Ther (2006) 3.15
Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology (2005) 3.00
Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol (2000) 2.96
Rational protein crystallization by mutational surface engineering. Structure (2004) 2.87
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci U S A (2002) 2.69
Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. Cell Metab (2012) 2.39
Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. J Proteome Res (2008) 2.27
The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem (2006) 2.15
On the origins of arrestin and rhodopsin. BMC Evol Biol (2008) 2.11
Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J (2008) 2.09
Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure (1996) 2.07
Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. Proc Natl Acad Sci U S A (2008) 1.97
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J Lab Clin Med (2003) 1.92
Thioredoxin signaling as a target for cancer therapy. Curr Opin Pharmacol (2007) 1.59
The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal. Structure (1996) 1.58
Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic Biol Med (2007) 1.56
Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J Biol Chem (2006) 1.54
Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure (1995) 1.53
Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci (2005) 1.50
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML. Blood (2011) 1.49
Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res (2005) 1.46
Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood (2008) 1.45
Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys (2004) 1.44
AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell (2013) 1.41
Hepatocellular carcinoma in Txnip-deficient mice. Oncogene (2006) 1.31
TXNIP links redox circuitry to glucose control. Cell Metab (2007) 1.27
TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms. Int J Biochem Cell Biol (2011) 1.26
Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid Redox Signal (2011) 1.24
Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1. J Biol Chem (2004) 1.24
Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer (2005) 1.23
Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum Pathol (2000) 1.20
The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol (2010) 1.18
The ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradation. J Biol Chem (2010) 1.16
The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol (2008) 1.16
Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol Ther (2010) 1.15
New algorithm for the identification of intact disulfide linkages based on fragmentation characteristics in tandem mass spectra. J Proteome Res (2010) 1.14
Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity. Nat Commun (2010) 1.13
Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis. Lab Invest (2005) 1.10
An expanded family of arrestins regulate metabolism. Trends Endocrinol Metab (2012) 1.10
Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis. PLoS One (2011) 1.05
Two-promoter vector is highly efficient for overproduction of protein complexes. Protein Sci (2004) 1.02
Assembly and solution structure of the core retromer protein complex. Traffic (2010) 1.01
Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability. J Biol Chem (2011) 0.98
Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease. Anticancer Res (2003) 0.94
Oxidation of biological thiols by highly reactive disulfide-S-oxides. Gen Physiol Biophys (2002) 0.89
hnRNP G elicits tumor-suppressive activity in part by upregulating the expression of Txnip. Biochem Biophys Res Commun (2008) 0.88
Endothelin-1- and isoproterenol-induced differential protein expression and signaling pathway in HL-1 cardiomyocytes. Proteomics (2010) 0.84
Structure of the N-terminal domain of human thioredoxin-interacting protein. Acta Crystallogr D Biol Crystallogr (2013) 0.81
Involvement of thioredoxin-binding protein 2 in the antitumor activity of CD437. Cancer Sci (2008) 0.79